Investing.com -- TD Cowen initiated coverage of Intuitive Surgical with a Buy rating and a $660 price target, saying the launch of the da Vinci 5 system is driving a long-tailed product cycle that can ...

The high-growth company has begun incorporating AI into its technology. The data it collects from surgeries could be used to ...

TD Cowen analysts Mathew Blackman and Drew Ranieri have named their top three medtech picks under their evolving “Bones, Bots ...

Intuitive Surgical has received FDA clearance for cardiac procedures using the da Vinci 5 surgical robot, according to a Jan. 26 report from Mass Device. The new cardiac clearances cover mitral valve ...

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

Cardiovascular disease remains the leading cause of death worldwide, claiming nearly 18 million lives each year.i More than ...

MemorialCare Long Beach Medical Center is a regional leader in robotic surgery with the new da Vinci 5. See how this tech ...

Bengaluru: Max Institute of Laparoscopic, Robotic, Bariatric Surgery & GI Surgery announced that it has entered into a ...

Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) Q4 2025 Earnings Call Transcript January 22, 2026 Intuitive Surgical, Inc. beats earnings expectations. Reported EPS is $2.53, expectations were $2.27. Operator: ...

TAMPA, FL, UNITED STATES, January 16, 2026 /EINPresswire.com/ -- With surgical robotics advancing faster than ever and ...

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...